A Phase 1 Clinical Trial to evaluate the effect of the study drug in people with moderate to severe Crohn's Disease.

Study number 5605 - RECRUITMENT CURRENTLY ON HOLD
Group People with moderate to severe Crohn's Disease
Gender Male / Female
Age 18 - 65
Location Liverpool
Compensation Up to a maximum of £4,552
Recruiting from Oct 2018
Additional details Study commitment last 30 weeks and consists of three 2-night residential stays on the CRU, in addition to a screening visit and 4 outpatient visits on the CRU. BMI between 18 – 35 kg/m2 (inclusive) with a body weight between 45 – 110kg.